HIV-protease inhibitors

被引:680
作者
Flexner, C
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Pharmacol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
关键词
D O I
10.1056/NEJM199804303381808
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1281 / 1292
页数:12
相关论文
共 95 条
[1]   REDUCTION OF THE IN-VITRO ACTIVITY OF A77003, AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE, BY HUMAN SERUM ALPHA(1) ACID GLYCOPROTEIN [J].
BILELLO, JA ;
BILELLO, PA ;
PRICHARD, M ;
ROBINS, T ;
DRUSANO, GL .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) :546-551
[2]   Severe hepatitis in three AIDS patients treated with indinavir [J].
Brau, N ;
Leaf, HL ;
Wieczorek, RL ;
Margolis, DM .
LANCET, 1997, 349 (9056) :924-925
[3]   SC-52151, A NOVEL INHIBITOR OF THE HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE [J].
BRYANT, M ;
GETMAN, D ;
SMIDT, M ;
MARR, J ;
CLARE, M ;
DILLARD, R ;
LANSKY, D ;
DECRESCENZO, G ;
HEINTZ, R ;
HOUSEMAN, K ;
REED, K ;
STOLZENBACH, J ;
TALLEY, J ;
VAZQUEZ, M ;
MUELLER, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (10) :2229-2234
[4]  
CAMERON DW, 1996, 11 INT C AIDS VANC B, V1, P24
[5]   Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24) :1962-1969
[6]  
CAVET W, 1996, 4 C RETR OPP INF WAS, P207
[7]  
Chiba M, 1996, DRUG METAB DISPOS, V24, P307
[8]   Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J].
Chun, TW ;
Carruth, L ;
Finzi, D ;
Shen, XF ;
DiGiuseppe, JA ;
Taylor, H ;
Hermankova, M ;
Chadwick, K ;
Margolick, J ;
Quinn, TC ;
Kuo, YH ;
Brookmeyer, R ;
Zeiger, MA ;
BarditchCrovo, P ;
Siliciano, RF .
NATURE, 1997, 387 (6629) :183-188
[9]   Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].
Chun, TW ;
Stuyver, L ;
Mizell, SB ;
Ehler, LA ;
Mican, JAM ;
Baseler, M ;
Lloyd, AL ;
Nowak, MA ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197
[10]  
COHEN C, 1996, 36 INT C ANT AG CHEM, P8